Suppr超能文献

抗炎作用部位及其对 LPS 诱导的急性肺损伤的保护作用。

Anti-Inflammatory Effect Fraction of and Its Protective Effect on LPS-Induced Acute Lung Injury.

机构信息

College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China.

Academy of Chinese Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.

出版信息

Mediators Inflamm. 2021 Mar 13;2021:6684120. doi: 10.1155/2021/6684120. eCollection 2021.

Abstract

is a well-known traditional Chinese herb with anti-inflammatory properties that is widely used in the treatment of lung conditions such as silicosis, tuberculosis, and pneumogastric hemorrhage. However, little information on the anti-inflammatory ingredients and their activities is available. In this study, an effect fraction of (EFBS) was enriched, and its anti-inflammatory activities and underlying mechanisms were investigated. EFBS was enriched by polyamide column chromatography and characterized by HPLC; an LPS-induced acute lung injury model was used to evaluate the anti-inflammatory activities of EFBS. Meanwhile, the main anti-inflammation-contributing ingredients and possible molecular mechanism of anti-inflammatory activity in EFBS were verified by component-knockout method combined with LPS-induced RAW264.7 cell model. The EFBS mainly consisted of coelonin (15.88%), batatasin III (32.49%), 3'--methylbatatasin III (6.96%), and 3-hydroxy-5-methoxy bibenzyl (2.51%). Pretreatment with the EFBS (20 mg/kg and 60 mg/kg) for five days prior to the administration of LPS resulted in decreases in wet-to-dry lung weight ratio, neutrophil number, MPO activity, total protein concentration, NO level, and MDA level, as well as IL-1, IL-6, MCP-1, and TNF- concentrations in the bronchoalveolar lavage fluid. Western blot analysis demonstrated the increased expressions of iNOS, COX-2, and NF-B p65 in the LPS treatment group, all of which were ameliorated by EFBS pretreatment. Histological examination confirmed the protective effect of the EFBS. Additionally, component-knockout assay confirmed that these four quantitative components contributed significantly to the anti-inflammatory effect of EFBS. Coelonin, batatasin III, 3'--methylbatatasin III and 3-hydroxy-5-methoxy bibenzyl were the main anti-inflammatory components of EFBS and could regulate the expression of downstream inflammatory cytokines by inhibiting p65 nuclear translocation. These findings uncover, in part, the molecular basis underlying the anti-inflammatory activity of .

摘要

是一种具有抗炎特性的著名中药,广泛用于治疗矽肺、肺结核和胃出血等肺部疾病。然而,关于其抗炎成分及其活性的信息很少。在这项研究中,我们富集了 (EFBS)有效部位,并研究了其抗炎活性及其作用机制。EFBS 通过聚酰胺柱色谱法进行富集,并通过 HPLC 进行表征;采用 LPS 诱导的急性肺损伤模型评价 EFBS 的抗炎活性。同时,通过成分敲除法结合 LPS 诱导的 RAW264.7 细胞模型,验证了 EFBS 的主要抗炎成分及其抗炎活性的可能分子机制。EFBS 主要由 coelonin(15.88%)、batatasin III(32.49%)、3'--methylbatatasin III(6.96%)和 3-羟基-5-甲氧基二苯并基(2.51%)组成。在 LPS 给药前用 EFBS(20mg/kg 和 60mg/kg)预处理 5 天,可降低湿重/干重肺重比、中性粒细胞数、MPO 活性、总蛋白浓度、NO 水平和 MDA 水平,以及支气管肺泡灌洗液中的 IL-1、IL-6、MCP-1 和 TNF-浓度。Western blot 分析表明,LPS 处理组 iNOS、COX-2 和 NF-B p65 的表达增加,EFBS 预处理可改善这些表达。组织学检查证实了 EFBS 的保护作用。此外,成分敲除试验证实这四个定量成分对 EFBS 的抗炎作用有显著贡献。coelonin、batatasin III、3'--methylbatatasin III 和 3-羟基-5-甲氧基二苯并基是 EFBS 的主要抗炎成分,可通过抑制 p65 核易位来调节下游炎症细胞因子的表达。这些发现部分揭示了 的抗炎活性的分子基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13c/7981185/bba5f5988ddc/MI2021-6684120.001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验